Virology
Evaluation of a commercially available Zika virus IgM ELISA: specificity in focus

https://doi.org/10.1016/j.diagmicrobio.201704002 Get rights and content

Abstract

Zika virus (ZIKV), an emerging arbovirus , has become the center of attention since it was linked to congenital abnormalities. Given the overlapping clinical picture of ZIKV disease with other infectious diseases and as an exigent public health matter, timely and reliable diagnosis of ZIKV infection is crucial. We evaluated the performance of a commercially available NS1-based ZIKV IgM ELISA. Our results showed suboptimal sensitivity within the first 5 days after onset while specificity remained robust.

Section snippets

Financial support

This study was supported by Cadham Provincial Laboratory internal research funds.

Conflict of interest

None Declared.

Acknowledgement

We would like to thank the Viral Zoonoses section at National Microbiology Laboratory in Winnipeg, Canada for their kind help.

References (21)

There are more references available in the full text version of this article.

Cited by (0)

View full text
Crown Copyright © 2017 Published by Elsevier Inc. All rights reserved.